Casey Toohill recently announced his retirement after a six-year NFL career and the defensive end admits to playing with a certain amount of “existential dread" when it came to the pounding his brain took during years of competitive football. "We have these clinical trials happening — we’re making progress,” said Toohill, now an advocate for former players with head injuries. Toohill became a member last month of the advisory board of the Concussion & CTE Foundation, which is joining with Emory University School of Medicine to start a clinical trial on whether an FDA-approved medication called baricitinib that reduces inflammation can improve depression and cognitive symptoms in former football players.